Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
Limi Adem,Gobezie T Tegegne
DOI: https://doi.org/10.2147/CIA.S358633
IF: 3.829
2022-04-17
Clinical Interventions in Aging
Abstract:Limi Adem, Gobezie T Tegegne Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia Correspondence: Gobezie T Tegegne, Email Background: Appropriate prescribing is often challenging in geriatric patients due to age-related pharmacokinetic and pharmacodynamic alterations. Elderly patients with cardiovascular diseases are frequently prescribed multiple medications. Hence, it is imperative to investigate medication appropriateness, polypharmacy, and drug-drug interactions in these groups of patients. Objective: To assess medication appropriateness using the 2019 American Geriatric Society Beers and Medication Appropriateness Index criteria, polypharmacy and drug-drug interactions among elderly ambulatory patients with cardiovascular diseases at Tikur Anbessa Specialized Hospital. Methods: A hospital-based retrospective cross-sectional study was conducted among 384 elderly (60 years and older) ambulatory patients with cardiovascular diseases between May 01-August 30, 2021. Data was collected from the patient's medical record using a data abstraction tool. The data were entered and analyzed using the SPSS program. Descriptive and logistic regression models were used to present the findings. Results: The most frequent diagnosis was hypertension (78.4%) followed by ischemic heart disease (31.3%). Averagely, 4.4 ± 2 medications were prescribed per patient. More than half of (53.1%) the patients received polypharmacy. According to Beer's and medication appropriateness index criteria, over one-third (28.1%) and the majority (95.1%) of the patients were prescribed potentially inappropriate medications, respectively. In addition, 53.1% and 90.1% of patients had polypharmacy, and were exposed to potential drug-drug interactions ranging from mild to major interactions, respectively. Further, polypharmacy was significantly associated with inappropriate medication prescribing. Conclusion: The study found that more than half of the patients got one or more potentially inappropriate medications in both criteria. The medication appropriateness index tool identified more potentially inappropriate medication than the Beers criteria. In addition, more than half of the patients got polypharmacy and had potential drug-drug interactions. Further, polypharmacy was significantly associated with inappropriate medication prescriptions. These findings highlight the need for interventions to improve appropriate prescribing practice among elderly patients. Keywords: inappropriate medication, polypharmacy, drug interaction, cardiovascular disease and elderly The world's aging population is speedily increasing from 9% to 16% between 2019 to 2050. 1 Increasing age is associated with higher rates of co-morbidity, disability (cognitive, mental, and functional impairments), 2 and multiple medication use. 3–5 Aging influences heart activities by decreasing cardiac muscle elasticity and the ability to respond to changes in pressure. 6 Hence, it is an independent risk factor for cardiovascular disease (CVD) which poses a great burden to elderly patients. 7 Globally, 32% of the deaths were due to CVD. Of which, three fourth of them were from low and middle-income countries. 8 Due to multiple chronic diseases, and age-related physiological changes that affect drugs' pharmacodynamics and pharmacokinetic properties, pharmacotherapy is complex and challenging in the elderly. 9 Polypharmacy, non-adherence, inappropriate medication prescription, 10,11 drug-drug interaction, 12,13 and medication-related problems 14 are frequent in elderly patients with CVD. Due to this, elderly patients are at a higher risk of adverse drug events (ADEs). 15 Explicit and implicit criteria are used to assess medication safety in the elderly. The explicit criteria (the 2019 American Geriatrics Society (AGS) Beers Criteria) 16 involves six medication appropriateness issues, while the implicit criteria (Medication Appropriate Index (MAI)) 17,18 uses ten criteria. The explicit criteria are primarily concerned with medications and assess how well they meet a set of predetermined criteria, criterion-based with rigid standards. On the other hand, the implicit criteria consider healthcare professionals' judgment to assess medication appropriateness. In Ethiopia, the pooled prevalence of CVD was 5% (1–20%) in the general population, 19 but its prevalence is expected to be higher in the elderly population. Despite CVD is the leading cause of death and disability among the elderly, 20 data are scarce regarding the appropriate use of medication -Abstract Truncated-
geriatrics & gerontology,gerontology